Acta Neuropathologica

Journal Title：Acta Neuropathologica

Acta Neuropathologica aims to publish the best papers on pathology of neurological disease, as well as experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues.

The journal publishes Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters).

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identiy of the subjects under study should be omitted.

Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.

The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.

Acta Neuropathologica 旨在发表关于神经系统疾病病理学的最佳论文，以及使用体外和体内模型的分子和细胞机制实验研究，最好通过分析人体组织进行验证。

该期刊发表原创论文、评论文章、病例报告和科学通讯（信件）。

提交出版的手稿必须包含一份声明，说明所有人类研究均已由适当的伦理委员会审查，因此已按照 1964 年《赫尔辛基宣言》适当版本规定的道德标准进行。文中还应明确说明，所有人在参与研究之前均已知情同意。应省略可能泄露研究对象身份的细节。

动物实验报告必须说明遵循了“实验室动物护理原则”（NIH 出版物编号 86-23，1985 年修订），以及适用的特定国家法律（例如德国动物保护法的现行版本）。

编辑保留拒绝不符合上述要求的稿件的权利。作者将对虚假陈述或未能满足上述要求承担责任。

Acta Neuropathologica创刊于1961年，由Springer Berlin Heidelberg出版商出版，收稿方向涵盖病理学 - 医学全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 偏慢,4-8周 ，影响因子指数9.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。